With interactive coaching and nightly sleep data tracking, MyAir helps increase CPAP usage, with 87% of patients achieving therapy compliance. (ResMed also launched a new CPAP mask today — read ...
[Image courtesy of ResMed] ResMed (NYSE: RMD) + announced today that it launched its new AirTouch N30i continuous positive airway pressure (CPAP) mask. ResMed says it developed the AirTouch N30i ...
NEW YORK — The morning after presenting an upbeat outlook to analysts in a gilded hall in the New York Stock Exchange building, Mick Farrell, the CEO of ResMed, looked refreshed, despite a post ...
After hours: October 18 at 5:16 PM EDT Loading Chart for RMD ...
Valued at $35.3 billion by market cap, San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications for ...
ResMed’s CPAP (continuous positive airway pressure) product, the AirFit N20. The California-based company, founded by Mr Farrell’s father in Sydney 35 years ago, is also listed on the ASX.
such as the AirTouch N30i next-generation CPAP mask unveiled earlier today. Capitalize on ResMed’s market opportunity and brand advantage in broader sleep health and breathing health adjacencies ...
Sleep and respiratory disorders sector of the medical device industry ("Sleep and Respiratory Care') and the supply of business management software as a service to out-of-hospital health providers ...
Learn More ResMed (ASX: RMD) shares are outperforming the market on Tuesday. In afternoon trade, the sleep disorder treatment company's shares are up 2% to $35.73. This compares favourably to a 0. ...
If you've been prescribed continuous positive airway pressure (CPAP) therapy to treat obstructive sleep apnea, your prescribed CPAP setting is related to several factors—the severity of your sleep ...
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing ...